Part,  Chapter, Paragraph

  1    -,     1           |              status of health through selected indicators and their trends
  2   II,     4.  2       |          shows the contribution of 13 selected causes of death to the increase
  3   II,     4.  2       |      expectancy by cause of death for selected EU countries for the periods
  4   II,     4.  2       |            2000. These countries were selected on the basis of availability
  5   II,     4.  2       |              birth by cause of death, selected countries.~ ~In most EU
  6   II,     4.  2       |            for men in 7 out of the 13 selected countries the decline in
  7   II,     4.  2       |        expectancy at birth 1980-2000, selected countries~ ~Table 4.2.5
  8   II,     4.  2       |            for men in 8 out of the 13 selected countries and for women
  9   II,     4.  2       |             life expectancy at birth, selected countries.~ ~The decline
 10   II,     4.  2       |             life expectancy at 65 for selected EU countries. Only countries
 11   II,     4.  2       |               successive decades were selected.~ ~Table 4.2.6. Average
 12   II,     4.  2       |             in life expectancy at 65, selected countries.~ ~Table 4.2.6
 13   II,     4.  2       |              that in 11 out of the 17 selected countries the increase in
 14   II,     4.  2       |          expectancy at the age of 80, selected countries.~ ~The conclusion
 15   II,     5.  1.  1   |         important at population level selected from WHO HFA database (htt 7)
 16   II,     5.  2.  2   |            ten years (1994-2003) were selected to estimate mortality trends.
 17   II,     5.  2.  2   |              at population level were selected: hypertension, hypercholesterol,
 18   II,     5.  3.  1   |          incident cases and deaths by selected cancer sites in EU25 (2006).~ ~
 19   II,     5.  3.  3   |         presented here subdivided per selected cancer site: stomach (ICD-9
 20   II,     5.  3.  3   |            indicator is available for selected European countries from
 21   II,     5.  4.  2   |         average results obtained on a selected population, but their results
 22   II,     5.  4.  6   |             the EU requires carefully selected indicators, which should
 23   II,     5.  5.  2   |               people with dementia in selected EUGLOREH countries~ ~The
 24   II,     5.  5.  3   |      comparison data on mortality for selected causes of death are not
 25   II,     5.  5.  3   |          absolute number of deaths in selected countries with respect to
 26   II,     5.  5.  3   |               et al, 2004) worldwide; selected data of studies from Western
 27   II,     5.  5.  3   |               different from those of selected populations followed during
 28   II,     5.  5.  3   |     employment have been performed in selected clinical samples and differing
 29   II,     5.  5.  3   |              of Multiple Sclerosis in selected EUGLOREH Countries~ ~Table
 30   II,     5.  5.  3   |              of Multiple Sclerosis in selected EUGLOREH Contries by gender~ ~
 31   II,     5.  5.  3   |              of Multiple Sclerosis in selected EUGLOREH Countries, by age (
 32   II,     5.  5.  3   |         patients by disease course in selected EUGLOREH countries~The distribution
 33   II,     5.  5.  3   |            disease severity (EDSS) in selected EUGLOREH countries~ ~MS
 34   II,     5.  5.  3   |            100 000) of MS patients in selected EUGLOREH countries~ ~The
 35   II,     5.  5.  3   |             of Parkinson’s disease in selected EUGLOREH countries~Incidence
 36   II,     5.  5.  3   |                Cost per case in PD in selected EUGLOREH countries (€PPP,
 37   II,     5.  5.  3   |            and of similar design were selected for this analysis. No studies,
 38   II,     5.  5.  3   |          Parkinson’s disease has been selected as one of the key diseases.
 39   II,     5.  6.  3   |           Osteoarthritis Incidence in selected European countries~ ~Table
 40   II,     5.  6.  3   |          Osteoarthritis Prevalence in selected EUGLOREH Countries~ ~Table
 41   II,     5.  6.  3   |             Radiographic Criteria) in selected European Countries ~ ~Figure
 42   II,     5.  6.  6   |           prevalence of arthritis and selected musculoskeletal disorders
 43   II,     5.  7.  3   |             chronic kidney disease in selected EUGLOREH countries.~ ~Figure
 44   II,     5.  9.  4   |            Survey I showed that seven selected allergens (Dermatophagoides
 45   II,     5.  9.  4   |               in vitro systems and on selected target cells. Provocation
 46   II,     5. 10.  3   |              Intervals per country in selected EUGLOREH countries~ ~Prevalence
 47   II,     5. 11.  3   |              disease.~ ~Prevalence of selected dermatological diseases
 48   II,     5. 11.  3   |           Table 5.11.1. Prevalence of selected dermatological diseases~ ~
 49   II,     5. 12.  2   |              of ethanol per year) for selected countries were derived from
 50   II,     5. 12.  3   |               the 1970-2002 period in selected European countries are given
 51   II,     5. 12.  3   |           mortality rates in men from selected EUGLOREH countries, 1970-
 52   II,     5. 12.  3   |         mortality rates in women from selected EUGLOREH countries, 1970-
 53   II,     5. 12.  3   |         mortality from the disease in selected countries (de la Pena et
 54   II,     5. 12.  6   |           mainly in very advanced and selected (i.e. comparatively younger)
 55   II,     5. 14.  3   |               12 year-old children in selected EUGLOREH countries~ ~Such
 56   II,     5. 14.  3   |          Edentulous people aged 65 in selected EUGLOREH countries~ ~The
 57   II,     5. 14.  3   |           Assessment (Pocket >6mm) in selected EUGLOREH countries~ ~Untreated,
 58   II,     5. 15.  4   |      Neurological diseases) have been selected for funding. They will serve
 59   II,     6.  3.  2   |            blood stream infections in selected EUGLOREH Countries.~ ~For
 60   II,     6.  3.  4   |         vaccination coverage in these selected groups, but also by adopting
 61   II,     6.  3.  4   |               countries.~ ~Annex 6.1. Selected tables and figures from
 62   II,     6.  3.  4   |             A1.1 TB cases per 100,000 selected countries and EU 25~Figure
 63   II,     7.  2.  2   |         available by country, sex and selected ICD codes at EuroStat (information
 64   II,     7.  2.  6   |        Emergency department data from selected Member State hospitals.
 65   II,     7.  2.  8   |              Interview Survey (ECHIS) selected indicators on injuries are
 66   II,     7.  3.  2   |            Figure 7.4).~ ~Figure 7.4. Selected causes of fatal injuries,
 67   II,     7.  3.  5   |              suicide attempts by sex, selected EUGLOREH countries~ ~This
 68   II,     7.  3.  5   |              Homicide, assault by sex selected EUGLOREH countries).~ ~Figure
 69   II,     7.  3.  5   |              Homicide, assault by sex selected EUGLOREH countries~ ~The
 70   II,     7.  4       |         Subsets of this list could be selected for further development
 71   II,     7.  4.  5   |           home and leisure accidents, selected EUGLOREH countries~ ~Analyses
 72   II,     8.  2.  1   |        opportunities9. The Group have selected the WHO’s ICF (2001) as
 73   II,     8.  2.  2   |               in each WHO region were selected for intensified assistance,
 74   II,     8.  2.  3   |           carried out in 590 randomly selected Swedish subjects aged from
 75   II,     9.  1.  1   |               and infant mortality in selected EUGLOREH countries~ ~
 76   II,     9.  1.  1   |            plurality~R: Prevalence of selected congenital anomalies~R:
 77   II,     9.  1.  1   |          Infant mortality by cause in selected EUGLOREH countries in 2005
 78   II,     9.  1.  1   |              per 1 000 live births in selected EUGLOREH countries, birth
 79   II,     9.  1.  1   |             cases, born 1990-1998, in selected EUGLOREH countries~ ~Cerebral
 80   II,     9.  1.  2   |     Mastroiacovo P (2006): "Trends of Selected Malformations in Relation
 81   II,     9.  2.  3   |              in children aged 0-14 in selected EUGLOREH CountriesBoys~ ~
 82   II,     9.  2.  3   |              in children aged 0-14 in selected EUGLOREH CountriesGirls~ ~
 83   II,     9.  3.  1   |              1 Premature mortality by selected causes of deaths in EU,
 84   II,     9.  3.  1   |           Prevalence And Incidence Of Selected Curable Sexually Transmitted
 85   II,     9.  3.  2   |           Maternal mortality ratio in selected EUGLOREH countries in 2004-
 86   II,     9.  3.  2   |             These indicators were not selected for the EURO-PERISTAT set
 87   II,     9.  4.  3   |             in trials, but tend to be selected because they are particularly
 88   II,     9.  5.  3   |          deaths for men and women for selected EUGLOREH countries~ ~Economic
 89   II,     9.  5.  3   |         patterns for men and women in selected EU countries. While a high
 90   II,     9.  5.  3   |       patterns among men and women in selected European countries~ ~Figure
 91  III,    10.  1       |        simplified scenarios involving selected determinants and their interrelationship (
 92  III,    10.  1.  3   |              Murray CJL et al (2002): Selected major risk factors and global
 93  III,    10.  2.  1   |               10.2.1.1.3. Deaths from selected causes (%), attributable
 94  III,    10.  2.  1   |             Bank.~ ~Table 10.2.1.1.4. Selected EUGLOREH countries and total
 95  III,    10.  2.  1(5)|                     See EMCDDA’s 2006 selected issues on drug use in recreational
 96  III,    10.  2.  1   |               from various studies in selected EU Countries for young adults (
 97  III,    10.  2.  1   |             chapter (Fig. 2 and 3).~ ~Selected multicentre studies~ ~-
 98  III,    10.  2.  1   |             aged 11, 13 and 15 years, selected countries in the WHO European
 99  III,    10.  2.  1   |          designs, dietary methods and selected population descriptors.
100  III,    10.  2.  1   |             will be validated in five selected countries with obviously
101  III,    10.  2.  1   |     vegetables and fruits and of some selected products is reported in
102  III,    10.  2.  1   |          apparent consumption of some selected products, 2004 (1 000 t)~ ~
103  III,    10.  2.  1   |             of disease attribution to selected major risk factors. Vol.
104  III,    10.  2.  1   |               estimated prevalence of selected cardiovascular and related
105  III,    10.  4.  2   |               the official control of selected contaminants:~ ~• Commission
106  III,    10.  4.  2   |        Exposure (MOE), i.e. the point selected on the dose-response curve
107  III,    10.  4.  3   |                information from eight selected European countries shows
108  III,    10.  4.  3   |              water-borne outbreaks in selected countries, 20002005~ ~The
109  III,    10.  4.  3   |      wastewater treatment facilities, selected European countries,1980-
110  III,    10.  4.  3   |              water. Priority diseases selected for target setting and reporting
111  III,    10.  4.  3   |               disease attributable to selected environmental factors and
112  III,    10.  4.  5   |         Hazardous waste generation in selected EU-25+EFTA, SEE and EECCA
113  III,    10.  5.  1   |         leisure accidents per year in selected EU countries).~ ~Floor space
114  III,    10.  5.  1   |        priority themes. These themes, selected in conjunction with stakeholders,
115  III,    10.  5.  2   |      settlement structure in 2003 for selected EUGLOREH countries~ ~Thereby,
116  III,    10.  5.  2   |        Percentage and total number of selected STI episodes in general
117  III,    10.  5.  3   |               compensation schemes in selected EU Countries has been carried
118  III,    10.  5.  3   |            who have a poor health are selected for the pool of the unemployed.
119  III,    10.  6.  1   |              and their time-trends in selected EU countries~ ~However,
120  III,    10.  6.  2   |          inequalities in mortality in selected European Countries per cause~ ~
121   IV,    11.  1.  5   |              in the initial OECD were selected on the basis of scientific
122   IV,    11.  1.  6   |        allowance, fee-for-service for selected services, target payments
123   IV,    11.  6.  4   |              available to compute the selected outcome indicators, the
124   IV,    11.  6.  4   |             available for most of the selected diseases, whereas clinical
125   IV,    12.  2       |        Policies and control tools for selected diseases~Cardiovascular
126   IV,    12.  2       |           control tools as applied to selected health determinants~ ~1.
127   IV,    12.  5       |   disability-free at age 65 years for selected EU Member States - men.~ ~
128   IV,    12.  5       |   disability-free at age 65 years for selected EU Member States - women.~ ~
129   IV,    12.  8       |             one third of all projects selected in 2005. The EEA and Norway130   IV,    12. 10       |           Policy documents adopted by selected Member States is given in
131   IV,    12. 10       |           disposal~High~Regional~ Yes~Selected chemical contaminants~High ~
132   IV,    12. 10       |            and waste disposal~ High~ ~Selected chemical contaminants~ High~ ~
133   IV,    12. 10       |          reporting (see www.rki.de).~ Selected activities:~National campaign “
134   IV,    12. 10       |               their subsequent use.~ ~Selected chemical contaminants~High
135   IV,    12. 10       |               Specific Information on selected conditions and their treatment
136   IV,    12. 10       |          participation by the public.~Selected chemical contaminants~High~
137   IV,    12. 10       |               provides an overview of selected key trends in health in
138   IV,    12. 10       |           have been placed in various selected points and keep the bag
139   IV,    12. 10       |        recycling program of batteries~Selected chemical contaminants~ High~
140   IV,    12. 10       |         environment 2003-2008 http ~ ~Selected chemical contaminants~ high~
141   IV,    12. 10       |       national Public Health Strategy~Selected chemical contaminants~intermediate~Law ~ ~
142   IV,    12. 10       | implementation of clinical waste plan~Selected chemical contaminants~ ~ ~ -
143   IV,    12. 10       |         campaign for children~http df~Selected chemical contaminants~intermediate~
144   IV,    12. 10       |      Information is given below about selected determinants concerning
145   IV,    12. 10       |             disposal~Intermediate~ ~ ~Selected chemical contaminants~High~
146   IV,    13.  1       |                  13.1. Differences in selected mortality indicators among
147   IV,    13.  1       |          Standardised Death Rates for selected non-communicable causes
148   IV,    13.  2.  2   |             of burden of diseases and selected health determinants~· In
149   IV,    13.  2.  3   |             of disease in 2000 due to selected health determinants for
150   IV,    13.  2.  3   |           have been calculated for 49 selected conditions. Table 13.7 presents
151   IV,    13.  9       |              Murray CJL et al (2002): Selected major risk factors and global